We are live on ! Find out more
CIP

Chartwell Investment Partners Portfolio holdings

AUM $2.91B
1-Year Est. Return 40.48%
This Fund
S&P 500
This Quarter Est. Return
+6.18%
1 Year Est. Return
+40.48%
3 Year Est. Return
+57.16%
5 Year Est. Return
+148.97%
10 Year Est. Return
+397.87%
AUM
$3.36B
AUM Growth
+$442M
Cap. Flow
+$136M
Cap. Flow %
4.03%
Top 10 Hldgs %
9.41%
Holding
519
New
111
Increased
138
Reduced
194
Closed
36

Sector Composition

Rank Sector Weight
1 Financials 16.99%
2 Technology 15.32%
3 Industrials 13.45%
4 Consumer Discretionary 10.47%
5 Healthcare 8.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SAGE
226
DELISTED
Sage Therapeutics
SAGE
$3.9M 0.12%
24,938
-3,495
-12% -$549K
EVR icon
227
Evercore
EVR
$11.8B
$3.9M 0.12%
36,952
-6,637
-15% -$684K
TDC icon
228
Teradata
TDC
$2.54B
$3.87M 0.12%
+96,439
New +$3.88M
BKNG icon
229
Booking.com
BKNG
$161B
$3.87M 0.12%
+47,725
New +$4.02M
HEI icon
230
HEICO Corp
HEI
$50.6B
$3.84M 0.11%
52,706
-1,659
-3% -$121K
NOC icon
231
Northrop Grumman
NOC
$80.8B
$3.84M 0.11%
+12,474
New +$4.12M
COHR icon
232
Coherent
COHR
$75.3B
$3.82M 0.11%
87,916
-3,082
-3% -$136K
MTZ icon
233
MasTec
MTZ
$21.1B
$3.81M 0.11%
75,143
-74,990
-50% -$3.62M
PFPT
234
DELISTED
Proofpoint, Inc.
PFPT
$3.79M 0.11%
32,876
-1,174
-3% -$143K
HUM icon
235
Humana
HUM
$45.8B
$3.77M 0.11%
+12,674
New +$3.71M
VG
236
DELISTED
Vonage Holdings Corporation
VG
$3.74M 0.11%
290,248
-10,393
-3% -$119K
BSX icon
237
Boston Scientific
BSX
$71.8B
$3.71M 0.11%
+113,470
New +$3.42M
EQT icon
238
EQT Corp
EQT
$32.5B
$3.71M 0.11%
123,382
+20,556
+20% +$574K
FIVN icon
239
FIVE9
FIVN
$2.56B
$3.67M 0.11%
106,071
+22,476
+27% +$728K
LOW icon
240
Lowe's Companies
LOW
$124B
$3.66M 0.11%
38,298
CADE
241
DELISTED
Cadence Bancorporation
CADE
$3.61M 0.11%
+125,008
New +$3.64M
MC icon
242
Moelis & Co
MC
$4.95B
$3.59M 0.11%
61,202
-8,116
-12% -$466K
TFIN icon
243
Triumph Financial Inc
TFIN
$1.83B
$3.58M 0.11%
+87,718
New +$3.54M
THG icon
244
Hanover Insurance
THG
$8.02B
$3.57M 0.11%
29,865
+8,455
+39% +$1.01M
EHC icon
245
Encompass Health
EHC
$12.5B
$3.57M 0.11%
66,264
-2,313
-3% -$116K
ARNA
246
DELISTED
Arena Pharmaceuticals Inc
ARNA
$3.56M 0.11%
81,725
-3,245
-4% -$139K
GTHX
247
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$3.54M 0.11%
81,467
-3,105
-4% -$133K
MTDR icon
248
Matador Resources
MTDR
$6.13B
$3.53M 0.1%
117,339
-4,457
-4% -$134K
PX
249
DELISTED
Praxair Inc
PX
$3.51M 0.1%
+22,209
New +$3.43M
PHM icon
250
Pultegroup
PHM
$24.9B
$3.51M 0.1%
121,937
-2,425
-2% -$73K

Similar funds

Chartwell Investment Partners's Q2 2018 Portfolio in Review

As of Q2 2018, Chartwell Investment Partners held 519 positions worth $3.36B, up 15% from $2.92B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

Chartwell Investment Partners deployed $136M of net new capital in Q2 2018, opening 111 new positions and adding to 138 existing holdings. Its largest new stake was LHC Group LLC: 302,334 shares worth $25.9M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Devon Energy, an estimated $12.6M trimmed.

  • Chartwell Investment Partners's largest Q2 2018 buy was LHC Group LLC: 302,334 shares worth $25.9M.
  • Chartwell Investment Partners added most to Microsoft in Q2 2018, an estimated $21M increase.
  • Chartwell Investment Partners's biggest Q2 2018 reduction was Devon Energy, cutting an estimated $12.6M.
  • Chartwell Investment Partners fully exited Haemonetics in Q2 2018, selling an estimated $25.5M.
  • Chartwell Investment Partners's ten largest holdings make up 9.4% of its $3.36B portfolio in Q2 2018.
  • Chartwell Investment Partners opened 111 new positions and closed 36 in Q2 2018.
  • Chartwell Investment Partners's portfolio value rose 15% quarter-over-quarter to $3.36B.

Based on Chartwell Investment Partners's 13F filing for Q2 2018, filed 9 Aug 2018.